Cure Research for Congestive Heart Failure
Cure Research list for Congestive Heart Failure:
The list of research areas and treatments under analysis mentioned
in various sources for Congestive Heart Failure
includes:
Latest Treatments for Congestive Heart Failure
Some of the more recent treatments for Congestive Heart Failure include:
Treatments for Congestive Heart Failure
Treatments to consider for Congestive Heart Failure may include:
Medical Research Breakthroughs and Congestive Heart Failure
Device based heart failure treatments: The use of mechanical devices
to treat patients with severe failure is gaining momentum. Some of the
mechanical devices include implantable cardiac defibrillators, biventricular
pacemakers and left ventricular assist devices (definitive Ventrassist).
The efficacy of these devices is good, but limitations include cost
and infection. Biventricular pacing or cardiac resynchronisation therapy
resynchronises cardiac contraction in patients with systolic congestive heart failure and
left bundle branch block. Ventrassist is based on a continuous flow
rotary blood pump that is surgically implanted in the abdominal wall
and attached to the apex of the ventricle.
Cure Research discussion for Congestive Heart Failure:
Investigations also are being done to improve heart transplantation for CHF
patients. In some cases, a heart transplant is the only possible treatment.
However, such patients face a shortage of donor hearts. A possible solution to
this critical shortage may be the use of a heart from other animals. Called
xenotransplantation, this procedure once was made difficult because of the
rejection of the heart by the CHF patient's immune system. However, new
technologies have been forged that can overcome such a barrier. For example,
scientists have been able to alter genes in the heart of a pig to diminish the
immune system reaction in a baboon. Scientists still need to discover how to
turn such genes on and off to prevent human rejection.
Researchers are continuing efforts to develop better devices to help the
damaged heart function. Already in use is a small mechanical pump called a left
ventricular assist device (LVAD). The ventricles are the heart's main pumping
chambers. These chambers enlarge as CHF progresses. Muscle fibers stretch, and
the heart loses strength. The LVAD is now used as a temporary assist for
patients with severe CHF who are awaiting a heart transplant. However,
researchers have found that the heart in patients with an LVAD often improves
after months of use--so much that a transplant is no longer needed. Thus,
efforts are underway to identify patients who may benefit from a longer-term
LVAD.
(Source: excerpt from NHLBI, Congestive Heart Failure Data Fact Sheet: NHLBI)
Medical research for Congestive Heart Failure: medical news summaries:
The following medical news items
are relevant to medical research for Congestive Heart Failure:
Congestive Heart Failure Treatment: Book Excerpts
Clinical Trials for Congestive Heart Failure
Some of the clinical trials for Congestive Heart Failure include:
Evidence Based Medicine Research for Congestive Heart Failure
Medical research papers related to Congestive Heart Failure include:
- Beta-blockers for congestive heart failure in children
- Digitalis for treatment of congestive heart failure in patients in sinus rhythm
- BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
- Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis
- Emergency thoracic ultrasound in the differentiation of the etiology of shortness of breath (ETUDES): sonographic B-lines and N-terminal pro-brain-type natriuretic peptide in diagnosing congestive heart failure
- Diuretics for heart failure
- Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure
- Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial
- Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure
- Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial
- Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure
- Patients with lone atrial fibrillation had low risk of progression to permanent atrial fibrillation, death, congestive heart failure, and stroke
- Hawthorn extract for treating chronic heart failure
- Diagnosis and Treatment of Acute and Chronic Heart Failure
- Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.
- Middle-aged people with chronic heart failure experienced the frustrations of living with an unpredictable and failing body
- Treatment of Chronic Heart Failure
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
- Chronic heart failure: overview of diagnosis and drug treatment in primary care
- Improving outcomes in chronic heart failure by early detection, drug therapy and patient support
- In acute CHF, can B-blockers be considered a safe and effective adjunct to typical measures?
- Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial
- Effects of group-based high-intensity aerobic interval training in patients with chronic heart failure
- Combined endurance-resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study
- Clinical and prognostic value of Duke`s Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
- Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease
- Long-term effects of a group-based high-intensity aerobic interval-training program in patients with chronic heart failure
- Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
- Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.
Click here to find more evidence-based articles on the TRIP Database
Congestive heart failure (CHF) is the most common heart condition in the elderly population, and every year nearly a half million new cases are...
CHF is a serious disease that will usually require medical treatment. But diet and exercise can play a crucial role in slowing the progression of the...
Nearly 60 million Americans are diagnosed with heart disease every year and it's the leading cause of death in both men and women. But...
Heart disease is the number one killer of American women, but it can be prevented. One way is to control your cholesterol levels. Find out how.
See full list of 22 related videos
» Next page: Deaths from Congestive Heart Failure
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: